Form 4: Director Gregory Summe Increases Stake in GRAIL, Inc.

Director Gregory Summe acquired 631 shares of GRAIL, Inc. common stock through a deferred stock unit program.

Summary

• Director Gregory Summe acquired 631 shares of common stock on April 15, 2026.
• The shares were acquired at a price of $49.79 per share.
• The acquisition was made in lieu of $31,438.36 in cash director fees.
• The total beneficial ownership for the director following this transaction is 39,754 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it reflects standard director compensation practices rather than a significant strategic shift.

Positives

• Director demonstrates alignment with shareholder interests by opting to receive equity in lieu of cash compensation.
• The shares vested immediately upon the grant date.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable as this is a routine insider transaction filing.

Industry Context

StockSavvy.ai notes that director participation in equity-based compensation programs is a standard corporate governance practice, signaling confidence in the company's long-term valuation.

Comparison to Industry Standards

• The use of deferred stock units in lieu of cash fees is a common practice among mid-to-large cap biotechnology and healthcare companies to preserve cash and align director incentives.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

GRAIL, GRAL, Insider Trading, Form 4, Director Compensation, Equity Grant